SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-007251
Filing Date
2020-05-08
Accepted
2020-05-08 17:19:32
Documents
14
Period of Report
2020-05-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K advm-20200508.htm   iXBRL 8-K 55364
  Complete submission text file 0001628280-20-007251.txt   202204

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20200508.xsd EX-101.SCH 2561
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT advm-20200508_cal.xml EX-101.CAL 708
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT advm-20200508_def.xml EX-101.DEF 1641
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20200508_lab.xml EX-101.LAB 23970
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20200508_pre.xml EX-101.PRE 12644
12 EXTRACTED XBRL INSTANCE DOCUMENT advm-20200508_htm.xml XML 11214
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 20861775
SIC: 2836 Biological Products, (No Diagnostic Substances)